
AbstractWe investigated the oncogenic role of SETDB1, focusing on non‐small cell lung cancer (NSCLC), which has high expression of this protein. A total of 387 lung cancer cases were examined by immunohistochemistry; 72% of NSCLC samples were positive for SETDB1 staining, compared to 46% samples of normal bronchial epithelium (106 cases) (p <0.0001). The percentage of positive cells and the intensity of staining increased significantly with increased grade of disease. Forced expression of SETDB1 in NSCLC cell lines enhanced their clonogenic growth in vitro and markedly increased tumour size in a murine xenograft model, while silencing (shRNA) SETDB1 in NSCLC cells slowed their proliferation. SETDB1 positively stimulated activity of the WNT–β‐catenin pathway and diminished P53 expression, resulting in enhanced NSCLC growth in vitro and in vivo. Our finding suggests that therapeutic targeting of SETDB1 may benefit patients whose tumours express high levels of SETDB1. Copyright © 2014 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Lung Neoplasms, Time Factors, Nude, Lung (rcdc), Neoplasm Grading (mesh), Mice, Pathology (science-metrix), Carcinoma, Non-Small-Cell Lung, Wnt Signaling Pathway (mesh), 1103 Clinical Sciences (for), SETDB1, Pathology, 2.1 Biological and endogenous factors, Animals (mesh), Transfection (mesh), Cell Proliferation (mesh), Aetiology, Non-Small-Cell Lung, 32 Biomedical and Clinical Sciences (for-2020), Lung, Wnt Signaling Pathway, Cancer, Cancer (rcdc), HCT116 Cells (mesh), Humans (mesh), Time Factors (mesh), Tumor, Tumor Burden (mesh), Lung Cancer, Tumourigenesis, Immunohistochemistry, Tumor Burden, Gene Expression Regulation, Neoplastic, 5.1 Pharmaceuticals, tumourigenesis, Lung Cancer (rcdc), RNA Interference, Development of treatments and therapeutic interventions, Tumor (mesh), Non-Small-Cell Lung (mesh), Histone-Lysine N-Methyltransferase (mesh), Nude (mesh), Immunohistochemistry (mesh), Clinical Sciences, Mice, Nude, Transfection, lung, WNT, 5.1 Pharmaceuticals (hrcs-rac), Biomarkers, Tumor, 3211 Oncology and carcinogenesis (for-2020), Animals, Humans, Protein Methyltransferases, Lung Neoplasms (mesh), Protein Methyltransferases (mesh), Cell Proliferation, Neoplastic, Neoplastic (mesh), Carcinoma, Tumor Suppressor Protein p53 (mesh), 2.1 Biological and endogenous factors (hrcs-rac), Cancer (hrcs-hc), 3202 Clinical sciences (for-2020), Histone-Lysine N-Methyltransferase, HCT116 Cells, Neoplasm Transplantation (mesh), 3211 Oncology and Carcinogenesis (for-2020), Gene Expression Regulation, Neoplasm Grading, Tumor Suppressor Protein p53, RNA Interference (mesh), Biomarkers, Neoplasm Transplantation
Lung Neoplasms, Time Factors, Nude, Lung (rcdc), Neoplasm Grading (mesh), Mice, Pathology (science-metrix), Carcinoma, Non-Small-Cell Lung, Wnt Signaling Pathway (mesh), 1103 Clinical Sciences (for), SETDB1, Pathology, 2.1 Biological and endogenous factors, Animals (mesh), Transfection (mesh), Cell Proliferation (mesh), Aetiology, Non-Small-Cell Lung, 32 Biomedical and Clinical Sciences (for-2020), Lung, Wnt Signaling Pathway, Cancer, Cancer (rcdc), HCT116 Cells (mesh), Humans (mesh), Time Factors (mesh), Tumor, Tumor Burden (mesh), Lung Cancer, Tumourigenesis, Immunohistochemistry, Tumor Burden, Gene Expression Regulation, Neoplastic, 5.1 Pharmaceuticals, tumourigenesis, Lung Cancer (rcdc), RNA Interference, Development of treatments and therapeutic interventions, Tumor (mesh), Non-Small-Cell Lung (mesh), Histone-Lysine N-Methyltransferase (mesh), Nude (mesh), Immunohistochemistry (mesh), Clinical Sciences, Mice, Nude, Transfection, lung, WNT, 5.1 Pharmaceuticals (hrcs-rac), Biomarkers, Tumor, 3211 Oncology and carcinogenesis (for-2020), Animals, Humans, Protein Methyltransferases, Lung Neoplasms (mesh), Protein Methyltransferases (mesh), Cell Proliferation, Neoplastic, Neoplastic (mesh), Carcinoma, Tumor Suppressor Protein p53 (mesh), 2.1 Biological and endogenous factors (hrcs-rac), Cancer (hrcs-hc), 3202 Clinical sciences (for-2020), Histone-Lysine N-Methyltransferase, HCT116 Cells, Neoplasm Transplantation (mesh), 3211 Oncology and Carcinogenesis (for-2020), Gene Expression Regulation, Neoplasm Grading, Tumor Suppressor Protein p53, RNA Interference (mesh), Biomarkers, Neoplasm Transplantation
| citations The total number of citations received by all articles of the researcher of interest. | 73 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
